Dogwood Therapeutics, Inc.
DWTX
$1.84
$0.010.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.99M | -3.78M | -15.74M | -3.81M | -10.93M |
| Total Depreciation and Amortization | 16.80K | 16.60K | 17.30K | 17.30K | 17.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 52.40K |
| Total Other Non-Cash Items | 495.40K | 82.40K | 12.09M | 60.00K | 6.42M |
| Change in Net Operating Assets | -112.80K | 44.30K | 361.70K | -296.00K | -243.00K |
| Cash from Operations | -4.59M | -3.64M | -3.27M | -4.03M | -4.68M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 3.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.40M | 86.40K | 0.00 | -- | 4.37M |
| Repurchase of Common Stock | -106.30K | -- | -- | -120.10K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -53.80K | -- | -- | -- |
| Cash from Financing | 11.29M | 32.60K | 0.00 | -120.10K | 7.37M |
| Foreign Exchange rate Adjustments | -1.00K | 2.70K | -3.30K | 10.10K | 1.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.70M | -3.60M | -3.28M | -4.14M | 2.69M |